Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
The world has faced numerous outbreaks of infectious agents over the last 20 years, including Ebola, influenza, Zika, and novel coronaviruses (SARS, MERS, COVID-19). These pathogens have caused global economic disruption and strained public health resources.
Thermo Fisher Scientific has been at the forefront of these outbreaks, supporting scientists with gold-standard genetic analysis solutions, services, and support.
Download whitepaper ''Overview of the pathology, pathogenicity, and epidemiology of SARS-CoV-2''
The most common areas of research related to infectious diseases are:
Blog post: SARS-CoV-2 |
Infographic: Quickly identify early emergence of the SARS-CoV-2 |
Blog post: Sanger Sequencing & NGS |
We offer comprehensive solutions that help with research into pathogenicity, host response, and underlying factors of host susceptibility and resistance.
Pathogen biologyCharacterization of a pathogen’s genomic structures and methods of replication can help inform mutational rate analysis, pathogenesis, and virulence. Our genetic analysis solutions for pathogen detection and genome analysis help with: • Detection of pathogen presence |
Host responseUnderstanding the host response to an infection can include large scale –omics and discovery approaches, targeted identification of important cells and proteins involved in the immune response. Our genetic analysis solutions for host response help with: • Identification of host genomic factors |
It is important to understand disease mechanisms and the associated biomarkers to identify drug-gene targets and vaccine targets for the best immune response.
Our genetic analysis solutions for vaccine/therapeutic discovery help with:
It is key to monitor strain evolution, outbreak management, environmental monitoring, and population genomics.
Our genetic analysis solutions for epidemiology help with:
Learn about the origins of SARS-CoV-2 and how its unique genetic make-up affects those infected by the virus.
Learn about the vaccine and therapy development process and how mRNA delivery made it possible to have vaccines ready in months.
Learn about the importance of virus tracking and how early warning has potentially stopped new variants.
For Research Use Only. Not for use in diagnostic procedures.